From where I sit the CR has done minimal damage at this point in time, admittedly it is mixed up in EOFY trading which again from where I sit
clouds a lot of trading patterns...note: in this regard EOFY is not current in Nasdaq considerations...Anyway in Aus, we have dilution that doesn't appear
to be overconcerning buyers and the consequence of this we have a n=750 registrational trial at the pointy end of where a drug needs to be
to get approval for commercialisation...We are well positioned to give EFTI a chance to prove itself, that's what it's all about...
From where I sit the CR has done minimal damage at this point in...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.8¢ |
Change
-0.003(0.83%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 31.3¢ | 29.5¢ | $931.9K | 3.093M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 33 | 282025 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 387365 | 27 |
View Market Depth
| Last trade - 14.26pm 17/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |